These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8239593)
21. Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam). Berman JD; Grogl M Exp Parasitol; 1988 Oct; 67(1):96-103. PubMed ID: 2844580 [TBL] [Abstract][Full Text] [Related]
22. Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing. Ibrahim ME; Hag-Ali M; el-Hassan AM; Theander TG; Kharazmi A Parasitol Res; 1994; 80(7):569-74. PubMed ID: 7855121 [TBL] [Abstract][Full Text] [Related]
23. Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model. Utaile M; Kassahun A; Abebe T; Hailu A Exp Parasitol; 2013 May; 134(1):68-75. PubMed ID: 23434530 [TBL] [Abstract][Full Text] [Related]
24. Complexation of antimony (Sb(V)) with guanosine 5'-monophosphate and guanosine 5'-diphospho-D-mannose: formation of both mono- and bis-adducts. Chai Y; Yan S; Wong IL; Chow LM; Sun H J Inorg Biochem; 2005 Dec; 99(12):2257-63. PubMed ID: 16214217 [TBL] [Abstract][Full Text] [Related]
25. Transcriptional responses of Leishmania (Leishmania) amazonensis in the presence of trivalent sodium stibogluconate. Patino LH; Muskus C; Ramírez JD Parasit Vectors; 2019 Jul; 12(1):348. PubMed ID: 31300064 [TBL] [Abstract][Full Text] [Related]
26. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani. Sinha R; Roychoudhury J; Palit P; Ali N Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907 [TBL] [Abstract][Full Text] [Related]
27. Identification of the benzodiazepines as a new class of antileishmanial agent. Clark RL; Carter KC; Mullen AB; Coxon GD; Owusu-Dapaah G; McFarlane E; Duong Thi MD; Grant MH; Tettey JN; Mackay SP Bioorg Med Chem Lett; 2007 Feb; 17(3):624-7. PubMed ID: 17113290 [TBL] [Abstract][Full Text] [Related]
28. A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities. Martinez S; Looker DL; Marr JJ Am J Trop Med Hyg; 1988 Mar; 38(2):304-7. PubMed ID: 2833127 [TBL] [Abstract][Full Text] [Related]
29. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents. Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205 [TBL] [Abstract][Full Text] [Related]
30. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs. Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243 [TBL] [Abstract][Full Text] [Related]
31. Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Berman JD; Gallalee JV; Best JM Biochem Pharmacol; 1987 Jan; 36(2):197-201. PubMed ID: 3028425 [TBL] [Abstract][Full Text] [Related]
32. An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani. Neal RA; Croft SL J Antimicrob Chemother; 1984 Nov; 14(5):463-75. PubMed ID: 6096347 [TBL] [Abstract][Full Text] [Related]
33. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates. Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301 [TBL] [Abstract][Full Text] [Related]
34. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody. Nabors GS; Farrell JP Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533 [TBL] [Abstract][Full Text] [Related]
35. Comparison of Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583 [TBL] [Abstract][Full Text] [Related]
36. Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals. Mottram JC; Coombs GH Exp Parasitol; 1985 Apr; 59(2):151-60. PubMed ID: 2982638 [TBL] [Abstract][Full Text] [Related]
37. Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate. El Fadili K; Imbeault M; Messier N; Roy G; Gourbal B; Bergeron M; Tremblay MJ; Légaré D; Ouellette M Antimicrob Agents Chemother; 2008 Feb; 52(2):526-33. PubMed ID: 18070969 [TBL] [Abstract][Full Text] [Related]
38. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Escobar P; Yardley V; Croft SL Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640 [TBL] [Abstract][Full Text] [Related]
39. Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism. Looker DL; Martinez S; Horton JM; Marr JJ J Infect Dis; 1986 Aug; 154(2):323-7. PubMed ID: 3014012 [TBL] [Abstract][Full Text] [Related]
40. Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms. Delgado G; Puentes F; Moreno A; Patarroyo ME Pharmacol Res; 2001 Oct; 44(4):281-6. PubMed ID: 11592861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]